Daniel Auge

697 total citations
10 papers, 581 citations indexed

About

Daniel Auge is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Daniel Auge has authored 10 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Infectious Diseases. Recurrent topics in Daniel Auge's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HIV/AIDS drug development and treatment (3 papers). Daniel Auge is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HIV/AIDS drug development and treatment (3 papers). Daniel Auge collaborates with scholars based in Germany, Switzerland and Czechia. Daniel Auge's co-authors include Martin F. Fromm, Jörg König, Maren Mieth, Ulrike Werner, N Wolf, Annick Seithel, Frank Dörje, Georg Heinkele, Katrin Singer and Renke Maas and has published in prestigious journals such as British Journal of Pharmacology, Investigative Ophthalmology & Visual Science and Journal of Molecular and Cellular Cardiology.

In The Last Decade

Daniel Auge

10 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Auge Germany 8 298 171 130 92 81 10 581
Hisanori Hara Switzerland 10 228 0.8× 112 0.7× 138 1.1× 67 0.7× 118 1.5× 26 590
Yayoi Hayashi Japan 17 269 0.9× 143 0.8× 84 0.6× 60 0.7× 197 2.4× 39 817
Yumiko Akamine Japan 12 230 0.8× 203 1.2× 134 1.0× 76 0.8× 56 0.7× 44 487
Hany Ghabrial Australia 14 204 0.7× 182 1.1× 327 2.5× 87 0.9× 104 1.3× 47 767
Mehraneh Khalighi United States 3 367 1.2× 176 1.0× 419 3.2× 72 0.8× 90 1.1× 5 702
Xavier Boulenc France 15 303 1.0× 94 0.5× 336 2.6× 78 0.8× 198 2.4× 19 814
Masato Taguchi Japan 18 183 0.6× 139 0.8× 259 2.0× 95 1.0× 131 1.6× 60 762
Tuija Tapaninen Finland 13 275 0.9× 128 0.7× 246 1.9× 88 1.0× 91 1.1× 20 582
P. Marathe United States 12 360 1.2× 211 1.2× 253 1.9× 100 1.1× 162 2.0× 19 745
Yasushi Yoshigae Japan 14 164 0.6× 81 0.5× 165 1.3× 96 1.0× 144 1.8× 27 568

Countries citing papers authored by Daniel Auge

Since Specialization
Citations

This map shows the geographic impact of Daniel Auge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Auge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Auge more than expected).

Fields of papers citing papers by Daniel Auge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Auge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Auge. The network helps show where Daniel Auge may publish in the future.

Co-authorship network of co-authors of Daniel Auge

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Auge. A scholar is included among the top collaborators of Daniel Auge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Auge. Daniel Auge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gessner, Arne, Maren Mieth, Daniel Auge, et al.. (2019). Establishment of reference values for the lysine acetylation marker Nɛ-acetyllysine in small volume human plasma samples by a multi-target LC–MS/MS method. Amino Acids. 51(9). 1259–1271. 6 indexed citations
2.
Müller, Fabian, Bertold Renner, Maren Mieth, et al.. (2014). N1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin–trimethoprim interaction. European Journal of Clinical Pharmacology. 71(1). 85–94. 89 indexed citations
3.
König, Jörg, Daniel Auge, Maren Mieth, et al.. (2013). PhaseIandIImetabolism andMRP2‐mediated export of bosentan in aMDCKIIOATP1B1‐CYP3A4‐UGT1A1‐MRP2quadruple‐transfected cell line. British Journal of Pharmacology. 169(1). 21–33. 20 indexed citations
4.
Mieth, Maren, et al.. (2012). Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1). Journal of Molecular and Cellular Cardiology. 53(3). 392–400. 54 indexed citations
5.
6.
Glaeser, Hartmut, Kathrin Mandery, Jörg König, et al.. (2010). The Prostaglandin Transporter OATP2A1 Is Expressed in Human Ocular Tissues and Transports the Antiglaucoma Prostanoid Latanoprost. Investigative Ophthalmology & Visual Science. 51(5). 2504–2504. 47 indexed citations
7.
Seithel, Annick, Katrin Singer, Daniel Auge, et al.. (2007). The Influence of Macrolide Antibiotics on the Uptake of Organic Anions and Drugs Mediated by OATP1B1 and OATP1B3. Drug Metabolism and Disposition. 35(5). 779–786. 168 indexed citations
8.
Bachmakov, Iouri, et al.. (2006). Characterization ofβ‐adrenoceptor antagonists as substrates and inhibitors of the drug transporter P‐glycoprotein1. Fundamental and Clinical Pharmacology. 20(3). 273–282. 67 indexed citations
9.
Hinz, Burkhard, Daniel Auge, Thomas Rau, et al.. (2003). Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high‐performance liquid chromatography. Biomedical Chromatography. 17(4). 268–275. 76 indexed citations
10.
Andreas, Stefan, et al.. (1991). [ST segmental changes and arrhythmias in obstructive sleep apnea].. PubMed. 45(9). 720–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026